Powered by BioRisk Atlas
32,000+ participants across MENA and GCC.
Portfolio-level, anonymized, aggregated.
PB-RVE models governable risk states and defines what changes operationally when a state shifts.
Outputs are expressed in portfolio terms: severity drift, loss ratio pressure, and renewal defensibility.
Designed for pilots and repeatable rollouts without claims system replacement or care delivery ownership.
Most health cost is committed upstream of where systems typically observe it. By the time risk is clinically coded or financially expressed, the trajectory is often already set.
PB-RVE shifts the observation window to the phase where risk is still forming and controllable, then translates that directionality into measurable economic impact.
Control is strongest when observation arrives before commitment.
Defined cohorts are stabilized and reversed before claims escalation, producing fast ROI and proof of controllability.
Directional risk states are translated into expected utilization and severity deltas, reducing downstream claims pressure.
Signals are aggregated into a portfolio Loss-Proxy Index that supports proactive pricing, underwriting, and renewal decisions.
Execution support can be provided through supervised programs for real-world validation, without disrupting insurer workflows.
PB-RVE Labs operates as an independent risk engineering platform. Data sources and execution partners are disclosed for validation and transparency only.